Dietary L-
citrulline is thought to modulate
muscle protein turnover by increasing
L-arginine availability. To date, the direct effects of increased L-
citrulline concentrations in muscle have been completely neglected. Therefore, we determined the role of L-
citrulline in regulating cell size during catabolic conditions by depriving mature C2C12 myotubes of
growth factors (serum free; SF) or
growth factors and nutrients (
HEPES buffered saline; HBS). Cells were treated with L-
citrulline or equimolar concentrations of
L-arginine (positive control) or
L-alanine (negative control) and changes in cell size and
protein turnover were assessed. In myotubes incubated in HBS or SF media, L-
citrulline improved rates of
protein synthesis (HBS: +63%, SF: +37%) and myotube diameter (HBS: +18%, SF: +29%). L-
citrulline treatment substantially increased iNOS
mRNA expression (SF: 350%, HBS: 750%). The general NOS inhibitor
L-NAME and the iNOS specific inhibitor
aminoguanidine prevented these effects in both models. Depriving myotubes in SF media of
L-arginine or
L-leucine, exacerbated wasting which was not attenuated by L-
citrulline. The increased iNOS
mRNA expression was temporally associated with increases in
mRNA of the
endogenous antioxidants SOD1, SOD3 and
catalase. Furthermore, L-
citrulline prevented
inflammation (LPS) and oxidative stress (H2O2) induced muscle cell wasting. In conclusion, we demonstrate a novel direct protective effect of L-
citrulline on skeletal muscle cell size independent of
L-arginine that is mediated through induction of the inducible NOS (iNOS)
isoform. This discovery of a nutritional modulator of iNOS
mRNA expression in skeletal muscle cells could have substantial implications for the treatment of muscle wasting conditions.